Advertisements



We"re likely to need coronavirus booster shots after the initial vaccine

Many leading coronavirus vaccines require two shots given weeks apart. But additional follow-up shots may be needed in the future to boost immunity. A volunteer receives an expe.....»»

Category: worldSource: nytNov 22nd, 2020

How the coronavirus vaccine development compares to other shots in history

The first flu vaccine was licensed for public use over a decade after the virus was isolated in a lab. Coronavirus research has moved much quicker. The invention of.....»»

Category: dealsSource: nytNov 19th, 2020

Pfizer says its COVID-19 vaccine 95% effective, will seek approval for emergency use from FDA

Pfizer says that more interim results from its ongoing coronavirus vaccine study suggest the shots are 95% effective and that the vaccin.....»»

Category: topSource: chicagotribuneNov 18th, 2020

Why experts say Moderna COVID-19 vaccine holds advantage over Pfizer’s candidate

The ability to store the Moderna coronavirus vaccine in a regular freezer would be a boon for distribution of the shots.The ability to store the Moderna coronavirus vaccine in a regular freezer would be a boon for distribution of the shots......»»

Category: topSource: chicagotribuneNov 17th, 2020

Moderna"s coronavirus vaccine requires 2 shots given a month apart, which makes it tougher to get everyone fully inoculated

Moderna"s coronavirus vaccine requires 2 shots given a month apart, which makes it tougher to get everyone fully inoculated.....»»

Category: personnelSource: nytNov 16th, 2020

20 million Americans could get a coronavirus vaccine next month, according to the head of Operation Warp Speed

Even more people could start receiving coronavirus shots next year, if the top experimental vaccines get a green light from regulators. Dr. Moncef Slaoui, .....»»

Category: dealsSource: nytNov 13th, 2020

Pfizer says its coronavirus vaccine is 90% effective. Here"s how that compares to shots for the flu, measles, and more.

Pfizer announced that its vaccine prevented COVID-19 in clinical trials. Here's how its efficacy compares to vaccines for chickenpox, flu, and more. A healthcare worker injects a patient wit.....»»

Category: smallbizSource: nytNov 9th, 2020

Dow posts roughly 330-point gain as IPO rush, deal-making fervor and vaccine hopes reignite stock buying

U.S. stocks on Monday closed sharply higher, amid fresh hope for a coronavirus vaccine, a flurry of initial public offerings and potential corporate deals, including reports that Oracle may be forging a p.....»»

Category: topSource: marketwatchSep 14th, 2020

Top drugmakers made a rare joint pledge not to cut corners on the coronavirus vaccine amid fears shots are being rushed before the presidential election

Top drugmakers made a rare joint pledge not to cut corners on the coronavirus vaccine amid fears shots are being rushed before the presidential election.....»»

Category: smallbizSource: nytSep 8th, 2020

Leading US drugmakers will sign a pact to produce a safe coronavirus vaccine amid concerns about shots being rushed to market before the presidential election

On Friday, President Trump said a vaccine would probably be available for distribution next month — despite experts saying it could take until 2021. .....»»

Category: personnelSource: nytSep 5th, 2020

Dr. Fauci is "cautiously optimistic" that by the end of 2021 there will be enough coronavirus vaccine shots for all Americans

Reuters, Al Drago/AFP via Getty Images Dr. Anthony Fauci is 'cautiously optimistic' that the.....»»

Category: topSource: businessinsiderAug 18th, 2020

This Bill Gates-backed coronavirus vaccine developer has skyrocketed 431% in just 2 days after going public (CVAC)

Reuters CureVac, a German biotechnology company, skyrocketed in its initial public offering on Friday, raising $213.3 million and more.....»»

Category: worldSource: nytAug 17th, 2020

Pfizer, BioNTech surge after the US government orders 100 million doses of COVID-19 vaccine (PFE, BNTX)

Pfizer and BioNTech announced Wednesday that the US government has placed an initial order for 100 million doses of its coronavirus vaccine. Shares of Pfizer jumped as much as 6% in premarket trading.....»»

Category: topSource: businessinsiderJul 22nd, 2020

The Fight Over a Coronavirus Vaccine Will Get Ugly

Once Covid-19 shots become available, there will be arguments about who gets them, and an even bigger battle with anti-vaxxers who refuse them......»»

Category: topSource: washpostJul 8th, 2020

Pfizer, BioNTech Report Promising Initial Data From Coronavirus Vaccine Study

Pfizer Inc. (NYSE: PFE), which is one of the five companies shortlisted by the U.S. read more.....»»

Category: blogSource: benzingaJul 1st, 2020

CDC, major vaccine manufacturers ramp up production of flu shots as the US braces for the potential simultaneous impact of the coronavirus and the seasonal flu

REUTERS/James Akena Major vaccine manufactures are planning to make millions more flu vaccine doses ahead of the fall amid mounting concern from the ongoing coronavirus pa.....»»

Category: topSource: businessinsiderJun 25th, 2020

Peninsula vaccine maker targets $100M IPO — but not for Covid

With the chief advisor for the Trump Administration's Covid-19 vaccine team as its chairman, vaccine developer Vaxcyte Inc. laid out plans for a $100 million initial public offering. But instead of targeting the coronavirus that has infected mor.....»»

Category: topSource: bizjournalsMay 26th, 2020

Pfizer begins vaccine tests on humans

Pfizer and BioNTech said Tuesday they have begun delivering doses of their experimental coronavirus vaccines for initial human testing in the United States. Fred Katayama reports......»»

Category: videoSource: reutersMay 5th, 2020

Photos capture the world"s first human trial of a potential coronavirus vaccine

AP Photo/Ted S. Warren The first human clinical trial of a potential COVID-19 vaccine was administered on Monday.  Four volunteers were given their first of two shots of the vaccine. Forty-fiv.....»»

Category: topSource: businessinsiderMar 17th, 2020

Why Making a Covid Vaccine Is Only the First Hurdle

In the quest to develop vaccines against Covid-19, researchers are on the cusp of overcoming challenges that typically require years if not decades to beat. After the first experimental shots produced positive results in late-stage trials -- a .....»»

Category: topSource: washpost57 min. ago

The creator of AstraZeneca"s coronavirus vaccine is a mom to triplets. Her children participated in the trial.

The vaccine's creator, Sarah Gilbert, had faith in its efficacy from the start — even when an "unexplained illness" halted the trials in September. Sarah Gilbert (top left), chief investigator of the Oxford coronavirus vaccine tri.....»»

Category: smallbizSource: nyt8 hr. 12 min. ago